It is a harrowing proposition: that in trying to control drug prices for 67 million Medicare patients now, we might inadvertently prevent the development of future drugs that could save lives. Implied, if not stated outright, is that we’re putting a cure for cancer or Alzheimer’s or some other intractable disease in jeopardy.

But we have good reasons to believe that the current policy won’t have such a trade-off any time soon. For one, pharma is hugely profitable, and these negotiated prices, while potentially chipping away at profit margins, should hardly entirely dampen the incentive to innovate, according to a couple of key studies of the industry. Two, if we are worried about future innovation, we should be focused on making it cheaper to develop drugs – and this is actually one area where AI is showing promise. By identifying the best candidates for possible treatments early in the research process, we could speed up development and continue to reduce costs — without losing out on tomorrow’s breakthroughs. …

  • lettruthout
    link
    fedilink
    English
    1024 months ago

    FTFY…

    Big Pharma claims lower prices will mean giving up miracle medications executive pay and bonuses.

      • circuscritic
        link
        fedilink
        25
        edit-2
        4 months ago

        The correct answer is neither.

        Miracle drugs are almost exclusively funded, or heavily subsidized, by the public sector. Typically through NIH grants, or other public funding mechanisms through the University system.

        R&D budgets for a big pharma go to things like reformulating existing brand name drugs, to prevent them going generic as they are supposed to under current law. Or other high return, reduced effort, drugs i.e. new dick pills, narcotics, etc.

        Executive pay and bonuses are not going anywhere, no matter what happens with these drug prices. They will cut their company to the bone, and then collude with private equity to take them private and gut it, before they ever considered cutting down their bonuses or stock options.

        • @[email protected]
          link
          fedilink
          134 months ago

          I benefit from an orphan drug, and the R&D was most definitely subsidised by the public purse.

          My insurance pays a few grand a month for it.

          The mfg coupon covers most of the rest, minus a copay.

          This is the second iteration of the original drug. The first hasn’t meaningfully fallen in price and only the original company can manufacture and distribute the generic even under the name of competitors.

          There was no breakthrough in the second iteration, and the logic to solve the “problem” they solved was straightforward. So now I pay more, for an anecdotally less effective version that addresses a risk irrelevant to me but present in the original.

          There is yet a third iteration on the way.

          Shock revelations:

          • pharma companies are greedy and will double dip against both government subsidies and patients/insurance at every opportunity.
          • XX Pharma didn’t pay for the original R&D, my gov did.
          • if one replaces Na with a/several similar elements, one still ends up with a salt, often resulting in a drug variant that “doesn’t affect blood pressure” and offers no other real benefits, nor risks.
          • Clinical trials for said alternative salt are broadly leas expensive than for the original. That does not result in lower prices.

          Nationalise pharma research, if not the manufacturers.

          Also, generics are often manufactured in countries with, shall we say, fewer controls and regulations. Know who makes those pills and where. If you can’t stomach the FDA reports on that manufacturer, find a pharmacy who will sell you something else…

  • @[email protected]
    link
    fedilink
    314 months ago

    Assuming lower prices were mandated in the future, what is their alternative? Develop zero new medications and subsist on the current drugs they offer with soon to expire patents? I doubt their competitors will be sitting idly by waiting for their eventual demise. Their argument is so superficial.

    • @[email protected]
      link
      fedilink
      English
      134 months ago

      I doubt their competitors will be sitting idly by waiting for their eventual demise

      That’s why you do M&As with your profits until there aren’t any competitors left

  • @[email protected]
    link
    fedilink
    224 months ago

    Won’t somebody think of the jobs in their marketing departments that have bigger budgets than the R&D departments?!?

    • @[email protected]
      link
      fedilink
      English
      12
      edit-2
      4 months ago

      Penicillin was a kind of miracle. But it wasn’t locked in a vault and used to extort a handful of wealthy people for every penny they were worth.

      The real miracle of penicillin was in how it got such universal adoption and use in so little time.

      • @[email protected]
        link
        fedilink
        94 months ago

        Science isn’t a miracle. It’s the hard work of scientists. Perhaps pharmaceutical companies should be required to operate with the same transparency as nonprofits.

  • @[email protected]
    link
    fedilink
    204 months ago

    Even if they’re right, that just means I won’t be able to afford those “Miracle Medications” anyway…

  • [email protected]
    link
    fedilink
    19
    edit-2
    4 months ago

    How could they possibly derive profits from drugs nearly wholly theorized and funded through government grants? Think of the shareholders and their inability to siphon your taxes into their pockets! Think about them often, especially when you pass by their offices visible through brittle glass. Let them know your feelings.

    • @[email protected]
      link
      fedilink
      English
      8
      edit-2
      4 months ago

      They aren’t wholly theorized and funded by the government.

      By far the most expensive step of drug development is the phase 3 clinical trial, the final stage before a drug can be released. The government doesn’t fund those at all. Government mostly funds pre-clinical trials (ie in animals or tissue culture) which are way cheaper.

      The average government grant for a biomed research proposal is nearly $600,000.

      The average phase 3 clinical trial costs $20 million.

        • @[email protected]
          link
          fedilink
          English
          4
          edit-2
          4 months ago

          Government-funded research is typically basic science research. It results in general knowledge that is usable by anyone, ie it does not support a specific product. No pharma company will pay for something that helps competitors as much (or possibly more) than it helps them.

          For example, government-funded research showed how injected mRNA could be directly absorbed and expressed by human cells in tissue culture. That remarkable discovery can be used by any pharma company to make a product. So pharma companies started developing various mRNA vaccines, and testing them in humans (Moderna, Pfizer, etc). But no pharma company would have funded the initial research that showed this was possible.

          • @[email protected]
            link
            fedilink
            English
            24 months ago

            Thanks for weighing in. Is there somewhere I can learn more about this? Big Pharma getting rich off tax payer funded research is an often repeated claim on internet forums, and I’d like to educate myself some more on this topic. Thanks!

            • @[email protected]
              link
              fedilink
              English
              2
              edit-2
              4 months ago

              In general, I think “Big Pharma gets rich off taxpayer funded research” is kind of like “Ford gets rich off taxpayer funded roads” or “Apple gets rich from taxpayer funded schools”. They are true in one sense, but that doesn’t mean those companies would pay for those things. That’s why government ends up paying for common goods.

              Note that “Big Pharma gets rich off taxpayer funded research” is different from “Big Pharma charges more than necessary to cover its own research costs.” You can find a pretty good analysis of those costs here.

  • @[email protected]
    link
    fedilink
    English
    164 months ago

    Without price controls only the rich will be able to afford those “miracle” cures anyway.

    • @[email protected]
      link
      fedilink
      English
      64 months ago

      This hits the point already. Look at those weight loss drugs that help people lose weight and are needed by certain other people.

      Look at all the celebrities all of a sudden on them and regular people’s insurance won’t cover them. The regular folks who need them have trouble getting them as a result.

  • Boozilla
    link
    fedilink
    English
    144 months ago

    I wouldn’t believe anything Big Pharma says.

    Big Pharma is so fucking greedy we’re already starting to run out of useful new antibiotics because they aren’t as profitable as Big Pharma wants.

  • AmidFuror
    link
    fedilink
    134 months ago

    The idea that better drugs will be discovered by AI is laughable, though. It can help the search, but it can’t predict the trial outcomes well. The system is too complex, and we don’t have the data.

    • @PenisDuckCuck9001
      link
      3
      edit-2
      4 months ago

      Trust me bro. One time I saw an ai claim that it’s possible to make lsd out of sodium chloride and distilled water. It was ai generated so it must be true.

  • Flying Squid
    link
    fedilink
    94 months ago

    Right. Because a miracle medication wouldn’t make a ton of money anyway what with it being a fucking miracle medication.